Baxter Bros’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09M Buy
5,176
+227
+5% +$45.5K 0.12% 93
2026
Q2
$941K Buy
4,949
+1,137
+30% +$195K 0.11% 95
2026
Q1
$644K Buy
3,812
+1,200
+46% +$205K 0.08% 107
2025
Q4
$441K Buy
2,612
+240
+10% +$39K 0.05% 121
2025
Q3
$342K Buy
+2,372
New +$324K 0.04% 128
2025
Q2
– Sell
-1,989
Closed -$254K – 155
2025
Q1
$254K Buy
1,989
+373
+23% +$50.6K 0.03% 138
2024
Q4
$214K Sell
1,616
-756
-32% -$106K 0.03% 152
2024
Q3
$345K Sell
2,372
-552
-19% -$79.9K 0.04% 127
2024
Q2
$401K Sell
2,924
-681
-19% -$90.9K 0.05% 119
2024
Q1
$495K Buy
3,605
+593
+20% +$81K 0.06% 108
2023
Q4
$409K Buy
3,012
+1,183
+65% +$144K 0.06% 113
2023
Q3
$224K Buy
+1,829
New +$233K 0.03% 137

Other funds holding IBB

Baxter Bros's IBB Position: Q3 2026 in Review

Baxter Bros increased its iShares Biotechnology ETF (IBB) stake by 4.6% in Q3 2026, buying an estimated $45.5K and bringing the position to 5,176 shares worth $1.09M. The position accounts for 0.12% of the portfolio, ranked #93.

Baxter Bros first reported a position in IBB in Q3 2023 and has held it in 12 quarters since. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Baxter Bros held 5,176 shares of iShares Biotechnology ETF worth $1.09M as of Q3 2026.
  • Baxter Bros bought 227 iShares Biotechnology ETF shares in Q3 2026, an estimated $45.5K.
  • iShares Biotechnology ETF made up 0.12% of Baxter Bros's portfolio in Q3 2026, its #93 holding.
  • Baxter Bros first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 12 quarters since.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Baxter Bros's 13F filing for Q3 2026, filed 4 Nov 2026.